ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SILK Silk Road Medical Inc

17.59
0.02 (0.11%)
Last Updated: 13:55:10
Delayed by 15 minutes

Period:

Draw Mode:

Volume 272,533
Bid Price 17.55
Ask Price 17.60
News -
Day High 17.59

Low
6.08

52 Week Range

High
45.41

Day Low 16.40
Company Name Stock Ticker Symbol Market Type
Silk Road Medical Inc SILK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.11% 17.59 13:55:10
Open Price Low Price High Price Close Price Prev Close
17.205 16.40 17.59 17.57
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,128 272,533 $ 16.86 $ 4,594,937 - 6.08 - 45.41
Last Trade Time Type Quantity Stock Price Currency
13:55:26 2 $ 17.575 USD

Silk Road Medical (SILK) Options Flow Summary

Overall Flow

Bullish

Net Premium

26k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Silk Road Medical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
680.46M 39.17M - 177.13M -55.74M -1.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Silk Road Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SILK Message Board. Create One! See More Posts on SILK Message Board See More Message Board Posts

Historical SILK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.5718.0616.4017.49565,5610.020.11%
1 Month18.7419.2816.4017.76500,559-1.15-6.14%
3 Months15.2322.5214.8017.14749,1302.3615.50%
6 Months6.4522.526.0812.88891,25611.14172.71%
1 Year44.9645.416.0816.61942,881-27.37-60.88%
3 Years58.2767.496.0829.10559,588-40.68-69.81%
5 Years35.8775.806.0833.98471,328-18.28-50.96%

Silk Road Medical Description

Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines the benefits of innovative endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy while maintaining a reduction in long-term stroke risk.

Your Recent History

Delayed Upgrade Clock